<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Strauss Vasquez | Activity</title>
	<link>https://www.catswannabecats.com/members/wormcan1/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/wormcan1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Strauss Vasquez.</description>
	<lastBuildDate>Wed, 24 Jun 2026 15:14:21 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">c31e80f6979f8d817ae5c5c5e1a85cc6</guid>
				<title>Strauss Vasquez posted an update: Our observations support the hypothesis that there are no [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25363/</link>
				<pubDate>Sun, 08 Jun 2025 21:25:36 -0400</pubDate>

									<content:encoded><![CDATA[<p>Our observations support the hypothesis that there are no potential hazards from blood or plasma transfusion of SARS-CoV-2-positive individuals with mild flu-like symptoms and more importantly of asymptomatic individuals.</p>
<p> In the light of the ongoing SARS-CoV-2 pandemic, convalescent plasma is a treatment option for CO-VID-19. In contrast to&hellip;<span class="activity-read-more" id="activity-read-more-25363"><a href="https://www.catswannabecats.com/activity/p/25363/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">aa2ed9a9c92e832e75d97d960e255445</guid>
				<title>Strauss Vasquez posted an update: Secondly, parameters such as the overpotential, Tafel slope, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23126/</link>
				<pubDate>Sat, 07 Jun 2025 23:33:13 -0400</pubDate>

									<content:encoded><![CDATA[<p>Secondly, parameters such as the overpotential, Tafel slope, active site, turnover frequency, and stability are used as indicators to measure the performance of catalytic electrode materials. Finally, taking the material cost of the catalytic electrode as a reference, the successful preparations are comprehensively compared. The overall aim is to&hellip;<span class="activity-read-more" id="activity-read-more-23126"><a href="https://www.catswannabecats.com/activity/p/23126/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6fbb6d4d4d11991a2ce3821824d06714</guid>
				<title>Strauss Vasquez posted an update: In group 1, diagnostic success was achieved in 136 out of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21483/</link>
				<pubDate>Fri, 06 Jun 2025 13:51:49 -0400</pubDate>

									<content:encoded><![CDATA[<p>In group 1, diagnostic success was achieved in 136 out of 185 biopsies (73.5%); whereas in group 2, diagnostic success was achieved in 219 out of 242 biopsies (90.50%), p&lt;0.0001. Out of the diagnostically unsuccessful biopsies in Group 1, 36 out of 49 (73.5%) were due to crush artifact; whereas crush artifact accounted for only 3 out of 23 (13.0%)&hellip;<span class="activity-read-more" id="activity-read-more-21483"><a href="https://www.catswannabecats.com/activity/p/21483/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9ff58ba7cc331f87cc91156a14ba5643</guid>
				<title>Strauss Vasquez posted an update: In group 1, diagnostic success was achieved in 136 out of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/21372/</link>
				<pubDate>Fri, 06 Jun 2025 13:34:44 -0400</pubDate>

									<content:encoded><![CDATA[<p>In group 1, diagnostic success was achieved in 136 out of 185 biopsies (73.5%); whereas in group 2, diagnostic success was achieved in 219 out of 242 biopsies (90.50%), p&lt;0.0001. Out of the diagnostically unsuccessful biopsies in Group 1, 36 out of 49 (73.5%) were due to crush artifact; whereas crush artifact accounted for only 3 out of 23 (13.0%)&hellip;<span class="activity-read-more" id="activity-read-more-21372"><a href="https://www.catswannabecats.com/activity/p/21372/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">66e30e7df7461390f7634ba5c3186c11</guid>
				<title>Strauss Vasquez posted an update: RNA offers nearly unlimited potential as a target for small [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19208/</link>
				<pubDate>Wed, 04 Jun 2025 12:49:10 -0400</pubDate>

									<content:encoded><![CDATA[<p>RNA offers nearly unlimited potential as a target for small molecule chemical probes and lead medicines. Many RNAs fold into structures that can be selectively targeted with small molecules. This Perspective discusses molecular recognition of RNA by small molecules and highlights key enabling technologies and properties of bioactive interactions.&hellip;<span class="activity-read-more" id="activity-read-more-19208"><a href="https://www.catswannabecats.com/activity/p/19208/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">265798172a34e64fc2311c069a5cf321</guid>
				<title>Strauss Vasquez posted an update: 4%) were readmitted for postoperative infection. Two [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17951/</link>
				<pubDate>Tue, 03 Jun 2025 12:25:17 -0400</pubDate>

									<content:encoded><![CDATA[<p>4%) were readmitted for postoperative infection. Two patients were diagnosed with meningitis (1.1%), one aseptic and one H. Influenza, and three patients developed surgical site infections (1.6%). One patient was empirically treated with antibiotics and ultimately had a negative CSF culture.</p>
<p> Our results demonstrate that the use of calcium&hellip;<span class="activity-read-more" id="activity-read-more-17951"><a href="https://www.catswannabecats.com/activity/p/17951/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d88cb4f9ee79c47007ecb34b6eef48de</guid>
				<title>Strauss Vasquez posted an update: Diabetic retinopathy (DR) is a vision-loss complication [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12788/</link>
				<pubDate>Sun, 01 Jun 2025 13:28:02 -0400</pubDate>

									<content:encoded><![CDATA[<p>Diabetic retinopathy (DR) is a vision-loss complication caused by diabetes with high prevalence. During DR, the retinal microvascular injury and neurodegeneration derived from chronic hyperglycemia have attracted global attention to retinal Müller cells (RMCs), the major macroglia in the retina contributes to neuroprotection. Protein Phosphatase&hellip;<span class="activity-read-more" id="activity-read-more-12788"><a href="https://www.catswannabecats.com/activity/p/12788/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f4809edf00bf16627cbc051ee78cd5e5</guid>
				<title>Strauss Vasquez posted an update: Medical cannabis, or cannabinoid-based products, continues [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5818/</link>
				<pubDate>Sat, 31 May 2025 15:21:41 -0400</pubDate>

									<content:encoded><![CDATA[<p>Medical cannabis, or cannabinoid-based products, continues to grow in popularity globally, driving the evolution of regulatory access frameworks; cancer patients and caregivers often rely on guidance from their physicians regarding cannabinoid-based treatments. But the majority of healthcare practitioners still feel unprepared and insufficiently&hellip;<span class="activity-read-more" id="activity-read-more-5818"><a href="https://www.catswannabecats.com/activity/p/5818/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3b6c75ed18f2df3cad652baa5346f3aa</guid>
				<title>Strauss Vasquez became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/5685/</link>
				<pubDate>Sat, 31 May 2025 15:10:48 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>